Current status of nucleic acid drugs and the challenges in regulatory science relating to quality control. Status, C., Drugs, N. A., Relating, R. S., & Control, Q. Regulatory Science of Medical Products, 7(2):113–120, 2017. tex.ids= satoshiobikaakifujisakaCurrentStatusNucleic2017
doi  bibtex   
@article{Status2017,
	title = {Current status of nucleic acid drugs and the challenges in regulatory science relating to quality control},
	volume = {7},
	issn = {2189-0447},
	doi = {10.14982/rsmp.7.113},
	number = {2},
	journal = {Regulatory Science of Medical Products},
	author = {Status, Current and Drugs, Nucleic Acid and Relating, Regulatory Science and Control, Quality},
	year = {2017},
	note = {tex.ids= satoshiobikaakifujisakaCurrentStatusNucleic2017},
	keywords = {\#nosource, CMC, nucleic acid drugs, oligonucleotides, quality control, regulatory science},
	pages = {113--120},
}

Downloads: 0